Minimal Residual Disease Negativity as the Primary Goal of Multiple Myeloma Therapy.
Saved in:
| Title: | Minimal Residual Disease Negativity as the Primary Goal of Multiple Myeloma Therapy. |
|---|---|
| Authors: | Cooperrider JH; Section of Hematology/Oncology, University of Chicago, 5841 S. Maryland Ave, MC 2115, Chicago, IL, 60637, USA., Derman BA; Section of Hematology/Oncology, University of Chicago, 5841 S. Maryland Ave, MC 2115, Chicago, IL, 60637, USA. bderman@bsd.uchicago.edu. |
| Source: | Drugs [Drugs] 2025 Oct; Vol. 85 (10), pp. 1231-1251. Date of Electronic Publication: 2025 Sep 04. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 7600076 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1950 (Electronic) Linking ISSN: 00126667 NLM ISO Abbreviation: Drugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1179-1950 |
|---|---|
| DOI: | 10.1007/s40265-025-02232-7 |
